Hypertension Trial, Recruiting (NCT05683093)

Hypertension Trial, Recruiting NCT05683093 Sponsor: University of Oxford Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT05683093 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to give your consent to take part in the study
You are male or female, aged between 30 and 40 years old at the time of joining
You previously took part in the ALSPAC study
You are able and willing to follow all the requirements of the study
You can read and understand English and can understand spoken English

Who may not be able to join:

You are currently pregnant or breastfeeding at the time of your first study visit
It has been less than six months since you gave birth
You are planning to donate blood within two weeks before your first study visit
You have a significant illness or condition that, in the opinion of the study doctor, could affect your ability to take part
You have a heart condition present from birth, or a long-term condition that significantly affects your heart or metabolism
You are found to be unsuitable for an MRI scan based on a screening check — though you may still be able to take part in other parts of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adam J Lewandowski, Cardiovascular Clinical Research Facility

Phone: 01865 226845

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05683093

Sponsor: University of Oxford

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 01865 226845

More information: https://clinicaltrials.gov/study/NCT05683093

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to give your consent to take part in the study
You are male or female, aged between 30 and 40 years old at the time of joining
You previously took part in the ALSPAC study
You are able and willing to follow all the requirements of the study
You can read and understand English and can understand spoken English

Who may not be able to join:

You are currently pregnant or breastfeeding at the time of your first study visit
It has been less than six months since you gave birth
You are planning to donate blood within two weeks before your first study visit
You have a significant illness or condition that, in the opinion of the study doctor, could affect your ability to take part
You have a heart condition present from birth, or a long-term condition that significantly affects your heart or metabolism
You are found to be unsuitable for an MRI scan based on a screening check — though you may still be able to take part in other parts of the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Oxford

Registry

ClinicalTrials.gov

Start date

17 November 2022

Est. completion

1 March 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Cardiac right ventricular mass

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov